Sika Interplant Q1 FY27: consolidated PAT -19% YoY as revenue slumps 37% on disruption
PAT -18.84% YoY · revenue -36.98% · margins expanding
₹42.86 Cr
-36.98% YoY
₹8.4 Cr
-18.84% YoY
18.52%
+3.7pp YoY
₹3.96
Sika Interplant Systems' consolidated revenue for Q1 FY27 came in at ₹42.86 Cr, down 36.98% year-on-year from ₹68.01 Cr in Q1 FY26, though up a modest 3.70% sequentially from ₹41.33 Cr in Q4 FY26. Consolidated PAT of ₹8.40 Cr fell a smaller 18.84% YoY (from ₹10.35 Cr) and rose 7.39% QoQ (from ₹7.82 Cr) — profit held up far better than the topline. There is no analyst/street consensus available for this micro-cap and no prior management guidance on record; neither our records nor a web search turned up a formal outlook to grade this print against, so vsStreet and vsGuidance are both unknown.
Q1 FY-2027 vs prior quarters
The YoY profit resilience came from margin expansion: net profit margin rose to 18.52% of total income from 14.84% a year ago, and the EBITDA-level operating margin (OPM) improved to 19.48% from 18.38%, as standalone raw-material cost eased to 76.6% of sales versus 80.6% a year ago. Sequentially, though, OPM compressed sharply — from 25.21% in Q4 FY26 to 19.48% now — because material cost this quarter (76.6% of sales) ran well above Q4's unusually low 51.7%, suggesting Q4's margin strength was a favourable cost-mix quarter rather than a new baseline. Standalone PAT of ₹8.48 Cr tracks consolidated PAT of ₹8.40 Cr within 1%, so the two bases tell the same story.
The stock went into the print at ₹1,096.05, down 6.6% over the past month of trading.
What the summary numbers don't show
Standalone PAT ₹8.48 Cr closely tracks consolidated ₹8.40 Cr ( — the 4 consolidated subsidiaries are immaterial — combined ₹1.30 Lakh revenue, ₹7.35 Lakh net loss, unreviewed by their own auditors.
Management explicitly attributes the revenue shortfall to supply-chain disruptions from "prevailing geopolitical tensions," which delayed execution and delivery of customer orders and deferred revenue recognition — the identical note appears in both the standalone and consolidated filings. The company's own same-day disclosure additionally flags that these geopolitical tensions are expected to impact Q2 FY27 performance as well, so the deferred revenue is not guided to reverse immediately. Basic EPS (consolidated) was ₹3.96 versus ₹4.88 a year ago and ₹3.72 in Q4 FY26. The results are unaudited — limited review only, by statutory auditors Rao & Emmar — and were approved at the August 14, 2026 board meeting.
W1
Whether the deferred revenue (down 37% YoY) recovers, given management's own August 14 disclosure that geopolitical-tension disruption is expected to extend into Q2 FY27.
W2
OPM trajectory — whether the sequential compression from 25.21% (Q4 FY26) to 19.48% (Q1 FY27) persists or reverses as raw-material cost as a share of sales normalises.
W3
Order execution and delivery timelines for the customer orders explicitly flagged as delayed this quarter, not yet quantified in the filing.
Figures in Rs. Lakhs in source, converted to Cr (÷100). No exceptional/extraordinary items either period. Results are unaudited — limited review only by Rao & Emmar (auditor's report, both statements). Consolidated includes 4 subsidiaries (Aerotek Sika Aviosystem, Emsac Engineering, Sikka N Sikka Engineers, Sika Tourism) that are individually unreviewed and immaterial (₹1.30 Lakh revenue, ₹7.35 Lakh net loss). Standalone and consolidated PAT diverge by <1%, no material basis split.